Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
2
1
0
TRICIDA INC Share · US89610F1012 · TCDA · A2JPBU (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of TRICIDA INC
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 55,11 M
Invested Funds
The following funds have invested in TRICIDA INC:
Fund | Vol. in million 7,68 | Percentage (%) 0,02 % |
Company Profile for TRICIDA INC Share
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Company Data
Name TRICIDA INC
Company Tricida, Inc.
Symbol TCDA
Website
https://www.tricida.com
Primary Exchange 
NASDAQ
NASDAQ
WKN A2JPBU
ISIN US89610F1012
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Gerrit Klaerner
Country United States of America
Currency USD
Employees 0,1 T
Address 7000 Shoreline Court, 94080 South San Francisco
IPO Date 2018-06-28
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | TCDA |
More Shares
Investors who hold TRICIDA INC also have the following shares in their portfolio:
